Wilson Glynn (CIK 0001405625)

Latest company ownership

Role: Chief Science Officer
Shares held
1,900,000
Last filed at
Mar 6, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
31,120
Last filed at
Oct 10, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2009Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 26, 2021 Jul 27, 2021 Safety Shot, Inc. Chief Science Officer Sell 22.5 -50,000 -6.25% $139.5K
Sep 22, 2017 Sep 26, 2017 Marker Therapeutics, Inc. Director Sell 95.0 +72,650 84.90% $87K
Nov 12, 2015 Nov 16, 2015 Marker Therapeutics, Inc. Director Buy 95.0 +401,782 28.05% $52.5K
Feb 26, 2014 Nov 13, 2015 Marker Therapeutics, Inc. Director Buy 97.5 +633,319 5217.66% $410.7K
Feb 17, 2012 Apr 24, 2012 Marker Therapeutics, Inc. CEO Buy 91.3 +166,667 15.92% $25K
Mar 23, 2011 Apr 5, 2011 Marker Therapeutics, Inc. CEO Buy 91.3 +147,059 16.34% $25K
Jun 29, 2009 Oct 26, 2009 Marker Therapeutics, Inc. Chair Buy 95.0 +900,000 100.00% $90K